Symphony Academy™: Medical Education Hosted by Circle Cardiovascular Imaging
Published: 05 April 2021
-
Views:
9515 -
Likes:
7
-
Views:
9515 -
Likes:
7
-
Up Next
-
10m 16sPart 4 | Session 9 Congenital CVD Post-Processing: Tetralogy Of Fallout Case Analysis
-
3m 5sPart 4 | Session 10 Congenital CVD Post-Processing: CHD Report
-
9m 1sPart 4 | Session 11 Congenital CVD Post-Processing: Neonatal 4D Flow
-
1m 11sPart 4 | Session 12 Congenital CVD Post-Processing: Closing Remarks
-
2m 22sPart 4 | Session 13 Adult CVD Post-Processing: Introduction
-
7m 50sPart 4 | Session 14 Adult CVD Post-Processing: Case 1 – Myocarditis
-
7m 57sPart 4 | Session 15 Adult CVD Post-Processing: Case 2 – HCM
-
4m 42sPart 4 | Session 16 Adult CVD Post-Processing: Case 3 – Hypertrophy
-
13m 33sPart 4 | Session 17 Adult CVD Post-Processing: Case 4 – Amyloidosis
-
6m 45sPart 4 | Session 18 Adult CVD Post-Processing: Case 5 – Post Op Ross Procedure
-
10mPart 4 | Session 19 Adult CVD Post-Processing: Case 6 – Left To Right Shunt
-
7m 50sPart 4 | Session 20 Adult CVD Post-Processing: Demo CVi42
-
3m 15sPart 1 | Session 1 Introduction Matthias Friedrich, Sven Plein, Dudley Pennell, João L Cavalcante, Chiara Bucciarelli-Ducci, Subha V Raman, Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
8m 3sPart 1 | Session 2 Pacemakers and NSF
-
8m 14sPart 1 | Session 3 LGE & Perfusion
-
4m 31sPart 1 | Session 4 Fast Imaging
-
3m 4sPart 1 | Session 5 Rest Perfusion
-
6m 40sPart 1 | Session 6 SMART
-
4m 12sPart 1 | Session 7 Low field MR
-
3m 19sPart 1 | Session 8 Interventional Cardiology with MR
-
3m 20sPart 1 | Session 9 Diffuse Tensor
-
5m 2sPart 1 | Session 10 Expert remote readers
-
3m 22sPart 2 | Session 1 Introduction
-
11mPart 2 | Session 2 Secrets for success of CMR
-
15m 1sPart 2 | Session 3 How do we further grow CMR field of action
-
15m 55sPart 2 | Session 4 Interplay, pros and cons
-
2m 44sPart 3 | Session 1 US Chest Pain Guidelines Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
2m 25sPart 3 | Session 2 CMR Guidelines Europe Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
2m 52sPart 3 | Session 3 CMR Guidelines UK Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
1m 51sPart 3 | Session 4 Impact Of CMR Guidelines Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
2m 6sPart 3 | Session 5 CT vs CMR Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
1m 52sPart 3 | Session 6 CT Affirmed Reimbursement Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
3m 17sPart 3 | Session 7 Advantages Of CMR Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
3m 24sPart 3 | Session 8 CMR Protocols Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
2m 7sPart 3 | Session 9 CMR Cost Effectiveness Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
4m 16sPart 3 | Session 10 CMR Current Global Reimbursement Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
3m 22sPart 3 | Session 11 CT-FFR Or Stress CMR Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
5m 13sPart 3 | Session 12 CMR Services Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
2m 45sPart 3 | Session 13 Challenges – Competitive Modalities Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
4m 35sPart 3 | Session 14 Challenges – Education Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
2m 58sPart 3 | Session 15 Increasing CMR Referrals Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
1m 10sPart 3 | Session 16 INCA Study Case Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
2m 33sPart 3 | Session 17 Super Fast Or Holistic Protocol Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
2m 51sPart 3 | Session 18 Future Of CMR – Role Of AI Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
4m 8sPart 3 | Session 19 Conclusions Tilman Emrich, Timothy Albert, Amedeo Chiribiri, Christopher Schneeweis
-
2m 19sPart 4 | Session 1 Congenital CVD Post-Processing: Introduction Dr Malenka Bissell
-
3m 4sPart 4 | Session 2 Congenital CVD Post-Processing: Sample Congenital Protocol Dr Malenka Bissell
-
5m 14sPart 4 | Session 3 Congenital CVD Post-Processing: Healthy Volunteer 2D Flow Dr Malenka Bissell
-
6m 3sPart 4 | Session 4 Congenital CVD Post-Processing: Healthy Volunteer Function and Strain Dr Malenka Bissell
-
4m 46sPart 4 | Session 5 Congenital CVD Post-Processing: Healthy Volunteer Visual Assessment Dr Malenka Bissell
-
10m 57sPart 4 | Session 6 Congenital CVD Post-Processing: Healthy Volunteer 4D Flow Dr Malenka Bissell
-
1m 14sPart 4 | Session 7 Congenital CVD Post-Processing: 2D Flow Background Dr Malenka Bissell
Overview
Circle Cardiovascular Imaging Inc. develops world class, advanced reading and reporting solutions for cardiac imaging. Circle is a prominent company for the global cardiac imaging community bringing together an experienced and qualified team of over 150 people.
Circle’s imaging platform, cvi42, is the best-in-class cardiovascular imaging reading and reporting solution for cardiac MR, cardiac CT, cardiac Interventional Planning and Electrophysiology. Annually, millions of cardiac exams - in over 1,000 hospitals and in more than 40 countries - are interpreted using cvi42, giving physicians the tools to accurately quantify and diagnose complex cardiovascular diseases whilst improving patient outcomes and the effective utilisation of healthcare resources. Currently at version 5.13.5, cvi42 fully embeds AI into one easy to use platform demonstrating capabilities within the same range as expert human readers.
Circle CVI recently launched the Symphony Academy as part of an effort to develop a global community for Medical Education. The aim is to provide an educational platform to share information that empowers and creates the conditions to achieve the best possible outcomes for patients.
We will be updating this page throughout the year with content designed to engage and educate viewers about the current state of cardiovascular imaging, help identify the meaningful technological advances we have already seen in reducing workflows and increasing efficiencies and interpret how future technology will continue to push the boundaries of cardiovascular imaging. You can also click HERE to listen to more audio talks in the Symphony Academy Educational Programme.
Symphony Academy Key Learning Objectives
- Recognize how state-of-the-art imaging diagnostics is contributing to improved outcomes in the treatment of CVD
- Identify the impact of current technological advances in reducing workflows and increasing efficiencies
- Interpret how future technology will continue to push the boundaries of cardiovascular imaging
- Recognize CMR evolution and achievements in history and expand on latest trend and reporting habits
Target Audience
- Imaging Specialists
- Cardiologists and Interventional Cardiologists
- Radiologists
- Electrophysiologists
- Technologists
More from this programme
Part 1
The Future of Cardiovascular Imaging Summit
Part 2
Routine use of CMR in Patients with Cardiovascular Disease
Part 3
The Dark Side of CMR: How To Dismantle The Wall Brick by Brick
Part 4
Congenital and Adult CVD Post-Processing
Faculty Biographies
Malenka Bissell
NIHR Academic Clinical Lecturer
Dr Malenka Bissell is a clinical lecturer in paediatric cardiology at the University of Leeds, UK.
Dr Bissell completed her DPhil in Oxford. Her research expertise includes 4D flow MRI, congenital heart disease and bicuspid aortic valve aortopathy.